Recap: CytomX Therapeutics Q4 Earnings

by

in

CytomX Therapeutics (NASDAQ:CTMX) reported its Q4 earnings results on Monday, March 11, 2024 at 04:05 PM.

Here’s what investors need to know about the announcement.

Earnings

CytomX Therapeutics beat estimated earnings by 133.0%, reporting an EPS of $0.01 versus an …

Full story available on Benzinga.com